Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
30
MYNZ Quote, Financials, Valuation and Earnings
Last price:
$1.14
Seasonality move
:
-2.03%
Day range:
$1.09 - $1.28
52-week range:
$0.92 - $8.20
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.52x
P/B ratio:
1.87x
Volume:
355.3K
Avg. volume:
702.8K
1-year change:
-83.23%
Market cap:
$6.1M
Revenue:
$894K
EPS (TTM):
-$57.66
Earnings Data
Next earnings date for MYNZ
--
Most recent earnings per share
-$9.80
Beat by $2.60
(Dec 31/2023)
Consensus Estimate
-$12.40
(Dec 31/2023)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MYNZ Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/28/2025 | Q2 | $400K | -- | -- | -$2.40 | -- |
| 04/01/2025 | Q1 | $300K | -- | -- | -$2.80 | -- |
| 03/25/2025 | Q4 | $300K | -- | -- | -$3.60 | -- |
| 10/21/2024 | Q3 | $250K | -- | -- | -$4.40 | -- |
| 09/25/2024 | Q2 | $300K | -- | -- | -$9.00 | -- |
| 06/24/2024 | Q1 | -- | -- | -- | -$7.60 | -- |
| 12/31/2023 | Q4 | $225K | $214.8K | -$9.80 | -$12.40 | $2.60 |
| 11/16/2023 | Q3 | $350K | $181.7K | -$15.78 | -$19.60 | $3.82 |
| 09/21/2023 | Q2 | -- | $248.9K | -$22.13 | -- | -- |
| 05/16/2023 | Q1 | -- | $250.1K | -$17.87 | -- | -- |
| 03/15/2023 | Q4 | -- | $193.3K | -$21.75 | -- | -- |
| 12/09/2022 | Q3 | -- | $96.8K | -$15.60 | -- | -- |
| 09/07/2022 | Q2 | -- | $139.2K | -$19.20 | -- | -- |
| 04/12/2022 | Q1 | -- | $100.6K | -$16.80 | -- | -- |
| 06/30/2021 | Q2 | -- | -- | -$0.80 | -- | -- |
| 03/31/2021 | Q1 | -- | -- | -$0.13 | -- | -- |
Mainz Biomed NV Earnings Questions
-
How Much did Mainz Biomed NV Generate in Revenue Last Quarter?
Mainz Biomed NV reported $214.8K worth of top line sales in its most recent quarter.
-
Did Mainz Biomed NV Beat Earnings Last Quarter?
Mainz Biomed NV announced earnings per share of -$9.80 which represents a beat of analyst forecast a -$12.40 per share.
-
Is Mainz Biomed NV Profitable?
Mainz Biomed NV reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Mainz Biomed NV EPS Next Year?
Mainz Biomed NV's earnings are forecast to decrease from -$22.36 per share to -$23.60 per share next year representing a decrease of -63.56%.
-
When is Mainz Biomed NV's Earnings Date?
Currently, Mainz Biomed NV has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 25, 2026.
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
